Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Kari Erichsen"'
Autor:
Arnold Berstad, Einar Kristoffersen, Eva Colás, Anne Marita Milde, Gunnar Nysoeter, Kari Erichsen
Publikováno v:
Drug Target Insights, Vol 2, Pp 221-228 (2007)
Background: Intestinal microbiota seems to play an essential role in the development of inflammatory bowel diseases (IBD). We hypothesised that an oral vaccine based on live Salmonella typhi would be well tolerated and could even attenuate dextran su
Externí odkaz:
https://doaj.org/article/6ef6a2b1d51f48bb978fdea59986af29
Autor:
Gunnar Nysœter, Kari Erichsen, Anne Marita Milde, Eva Colás, Einar Kristoffersen, Arnold Berstad
Publikováno v:
Drug Target Insights, Vol 2 (2007)
Background Intestinal microbiota seems to play an essential role in the development of inflammatory bowel diseases (IBD). We hypothesised that an oral vaccine based on live Salmonella typhi would be well tolerated and could even attenuate dextran sul
Externí odkaz:
https://doaj.org/article/f54c82aae8b64bd3831a57b3f036c30c
Autor:
Gunnar Nysoeter, Kari Erichsen, Anne Marita Milde, Eva Colás, Einar Kristoffersen, Arnold Berstad
Publikováno v:
Drug Target Insights, Vol 2, Iss 1 (2007)
Abstract non disponibile
Externí odkaz:
https://doaj.org/article/7fbe040c2da04058a18e8b0b342bfac6
Autor:
Gülen Arslan, Kari Erichsen, Anne Marita Milde, Lars Helgeland, Tormod Bjørkkjær, Livar Frøyland, Arnold Berstad
Publikováno v:
Integrative Medicine Insights, Vol 2, Pp 25-34 (2007)
Infectious Diseases, Vol 2 (2007)
Infectious Diseases, Vol 2 (2007)
Background Omega-3 (n-3) polyunsaturated fatty acids (PUFAs) have modulating effects in several chronic inflammatory conditions. The aim of the present study was to test whether prior short-term dietary supplementation with n-3 (fish or seal oil) or
Publikováno v:
Alimentary pharmacologytherapeutics. 22(9)
Background Iron deficiency is a common complication of inflammatory bowel disease. Oral iron therapy may reinforce intestinal tissue injury by catalyzing production of reactive oxygen species. Aim To compare the effects of ferrous sulphate and non-io
Autor:
Jens Ostborg, Trygve Hausken, Gunnar Nysaeter, Kari Erichsen, Arnold Berstad, Rune J. Ulvik, Rolf K. Berge, Jack Johansen
Publikováno v:
Scandinavian journal of gastroenterology. 40(9)
Iron therapy may reinforce intestinal inflammation by catalysing production of reactive oxygen species. The effects of oral ferrous fumarate and intravenous iron sucrose on clinical disease activity and plasma redox status were investigated in patien
Autor:
Trygve Hausken, Anne Marita Milde, Kari Erichsen, Oddrun Anita Gudbrandsen, Lars Helgeland, Gülen Arslan, Arnold Berstad, Rune J. Ulvik, Rolf K. Berge
Publikováno v:
Inflammatory bowel diseases. 11(8)
Background: Oral ferrous iron therapy may reinforce intestinal inflammation. One possible mechanism is by catalyzing the production of reactive oxygen species. We studied the effects of low-dose oral ferrous fumarate on intestinal inflammation and pl
Autor:
Kari Erichsen
Publikováno v:
Scandinavian journal of gastroenterology. 39(8)
Publikováno v:
Scandinavian journal of gastroenterology. 38(5)
Iron deficiency anaemia is a frequent complication of Crohn disease. Treatment with ferrous iron (Fe2-) compounds is often unsatisfactory and is associated with gastrointestinal side effects. Theoretically, oral iron supplementation may even be harmf
Autor:
Kari Erichsen, Arnold Berstad, Einar K. Kristoffersen, Anne Marita Milde, Gunnar Nysœter, Eva Colás
Publikováno v:
Drug Target Insights, Vol 2, Pp 221-228 (2007)
Drug Target Insights
Drug Target Insights, Vol 2 (2007)
Drug Target Insights
Drug Target Insights, Vol 2 (2007)
Background: Intestinal microbiota seems to play an essential role in the development of inflammatory bowel diseases (IBD). We hypothesised that an oral vaccine based on live Salmonella typhi would be well tolerated and could even attenuate dextran su